Mechanisms of action of Fu Fang Gang Liu liquid in treating condyloma acuminatum by network pharmacology and experimental validation
暂无分享,去创建一个
Bingnan Cui | Chenchen Xu | Z. Fan | Jiao Yang | Shuxin Wang
[1] M. Kanehisa,et al. KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..
[2] Xinyu Jiang,et al. The mechanism of action of the combination of Astragalus membranaceus and Ligusticum chuanxiong in the treatment of ischemic stroke based on network pharmacology and molecular docking. , 2022, Medicine.
[3] Jingwen Chen,et al. Prediction and validation of potential molecular targets for the combination of Astragalus membranaceus and Angelica sinensis in the treatment of atherosclerosis based on network pharmacology , 2022, Medicine.
[4] X. Zhang,et al. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation. , 2022, Journal of ethnopharmacology.
[5] Yuanjun Yin,et al. Based on network pharmacology and in vitro experiments to prove the effective inhibition of myocardial fibrosis by Buyang Huanwu decoction , 2022, Bioengineered.
[6] W. Wang,et al. Hiplot: a comprehensive and easy-to-use web service boosting publication-ready biomedical data visualization , 2022, bioRxiv.
[7] N. Bhari,et al. Asian guidelines for condyloma acuminatum. , 2022, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[8] K. Zeng,et al. Identification of novel biomarkers and key pathways of condyloma acuminata. , 2022, Genomics.
[9] Yi Cheng,et al. Periplocymarin Induced Colorectal Cancer Cells Apoptosis Via Impairing PI3K/AKT Pathway , 2021, Frontiers in Oncology.
[10] D. Barh,et al. Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics , 2021, Biomolecules.
[11] Xiaochen Bo,et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.
[12] Yi Zhao,et al. KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis , 2021, Nucleic Acids Res..
[13] Z. Dong,et al. Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3 , 2021, Oncogene.
[14] Miranda Thomas,et al. Human papillomavirus E6 and E7: What remains? , 2021, Tumour virus research.
[15] Alix Warburton,et al. Persistent Human Papillomavirus Infection , 2021, Viruses.
[16] T. Jin,et al. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation , 2021, Frontiers in Public Health.
[17] Naiqiang Zhu,et al. Molecular mechanism of the anti-inflammatory effects of Sophorae Flavescentis Aiton identified by network pharmacology , 2021, Scientific Reports.
[18] Peter B. McGarvey,et al. UniProt: the universal protein knowledgebase in 2021 , 2020, Nucleic Acids Res..
[19] David S. Goodsell,et al. RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences , 2020, Nucleic Acids Res..
[20] Benjamin A. Shoemaker,et al. PubChem in 2021: new data content and improved web interfaces , 2020, Nucleic Acids Res..
[21] Ling Guo,et al. Mechanism of Action of Periplogenin on Nasopharyngeal Carcinoma Based on Network Pharmacology and Experimental Study of Vitamin E Coupled with Periplogenin Self-Assembled Nano-Prodrug for Nasopharyngeal Carcinoma. , 2020, Journal of biomedical nanotechnology.
[22] R. Gilson,et al. 2019 IUSTI‐Europe guideline for the management of anogenital warts , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.
[23] A. Corvalán,et al. Human Papillomavirus 16 E7 Promotes EGFR/PI3K/AKT1/NRF2 Signaling Pathway Contributing to PIR/NF-κB Activation in Oral Cancer Cells , 2020, Cancers.
[24] Rita Kundu,et al. Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy , 2020, Frontiers in Microbiology.
[25] F. Sanz,et al. The DisGeNET knowledge platform for disease genomics: 2019 update , 2019, Nucleic Acids Res..
[26] Minoru Kanehisa,et al. Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.
[27] Olivier Michielin,et al. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules , 2019, Nucleic Acids Res..
[28] K. Zeng,et al. 5-aminolevulinic acid photodynamic therapy reduces HPV viral load via autophagy and apoptosis by modulating Ras/Raf/MEK/ERK and PI3K/AKT pathways in HeLa cells. , 2019, Journal of photochemistry and photobiology. B, Biology.
[29] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[30] Wei Zhang,et al. ETCM: an encyclopaedia of traditional Chinese medicine , 2018, Nucleic Acids Res..
[31] Jian-Qin Wang,et al. Expression of Caspase 8 and phospho-Akt in condyloma acuminatum lesions , 2017 .
[32] Xuemin Qiu,et al. Traditional Chinese medicine for human papillomavirus (HPV) infections: A systematic review. , 2017, Bioscience trends.
[33] Xia Wang,et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database , 2017, Nucleic Acids Res..
[34] Jiangnan Yu,et al. Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy , 2017, Drug delivery.
[35] Nicolas Wentzensen,et al. Carcinogenic human papillomavirus infection , 2016, Nature Reviews Disease Primers.
[36] Huiyun Zhang,et al. Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation , 2016, Oncotarget.
[37] L. Denny. MANAGEMENT OF HPVAND ASSOCIATED CERVICAL LESIONS ( L DENNY , SECTION EDITOR ) Epidemiology and Burden of Disease Associated with HPV Infection , 2016 .
[38] Xianling Cong,et al. Correlation of human papillomavirus types with clinical features of patients with condyloma acuminatum in China , 2016, International journal of dermatology.
[39] Yuan-wen Wang,et al. Tumor targeted delivery of octreotide-periplogenin conjugate: Synthesis, in vitro and in vivo evaluation. , 2016, International journal of pharmaceutics.
[40] M. Ling,et al. The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses , 2015, Molecular Cancer.
[41] Eric O'Neill,et al. PI3K/Akt-mediated regulation of p53 in cancer. , 2014, Biochemical Society transactions.
[42] Xin He,et al. Periplocymarin is a potential natural compound for drug development: highly permeable with absence of P‐glycoprotein efflux and cytochrome P450 inhibitions , 2014, Biopharmaceutics & drug disposition.
[43] Wei Zhou,et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.
[44] Mario Schelhaas,et al. Concepts of papillomavirus entry into host cells. , 2014, Current opinion in virology.
[45] C. Chen,et al. Phosphatidylinositol 3-kinase signaling as a therapeutic target for cervical cancer. , 2013, Current cancer drug targets.
[46] M. Wagner,et al. Systematic review of the incidence and prevalence of genital warts , 2013, BMC Infectious Diseases.
[47] Dingquan Yang,et al. Expressions of phosphatidylinositol 3 kinase and phosphorylated Akt in condyloma acuminatum and cervical squamous cell carcinoma , 2011 .
[48] C. Catricalà,et al. Human Papillomaviruses, p16INK4a and Akt expression in basal cell carcinoma , 2011, Journal of experimental & clinical cancer research : CR.
[49] C. Meijer,et al. PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro , 2011, Molecular Cancer.
[50] P. Delvenne,et al. Mechanisms of cell entry by human papillomaviruses: an overview , 2010, Virology Journal.
[51] A. Braca,et al. Pro-apoptotic and cytostatic activity of naturally occurring cardenolides , 2009, Cancer Chemotherapy and Pharmacology.
[52] A. Contreras-Paredes,et al. E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway. , 2009, Virology.
[53] Robert A Newman,et al. Cardiac glycosides as novel cancer therapeutic agents. , 2008, Molecular interventions.
[54] D. McCance,et al. Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. , 2006, Cancer research.
[55] Y. Bang,et al. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt , 2006, Cellular and Molecular Life Sciences CMLS.
[56] D. Pim,et al. Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A , 2005, Oncogene.
[57] Xian Xu,et al. [Clinical efficacy of compound periploca liquid in treating condyloma acuminatum and its effect on human papilloma virus DNA expression in vitro]. , 2005, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
[58] J. Doorbar. The papillomavirus life cycle. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[59] Michelle S. Longworth,et al. Pathogenesis of Human Papillomaviruses in Differentiating Epithelia , 2004, Microbiology and Molecular Biology Reviews.
[60] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[61] M. Scheffner,et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.
[62] J. Woodgett,et al. Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. , 1991, European journal of biochemistry.
[63] K. Münger,et al. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. , 1989, The EMBO journal.
[64] H. Itokawa,et al. Studies on chemical constituents of antitumor fraction from Periploca sepium BGE. I. , 1987, Chemical & pharmaceutical bulletin.
[65] S. Staal. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[66] Tsippi Iny Stein,et al. The GeneCards Suite , 2021, Practical Guide to Life Science Databases.
[67] Practical Guide to Life Science Databases , 2021 .
[68] M. Aoki,et al. Oncogenic Roles of the PI3K/AKT/mTOR Axis. , 2017, Current topics in microbiology and immunology.
[69] A. Hopkins. Network pharmacology , 2007, Nature Biotechnology.
[70] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..